These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1145 related items for PubMed ID: 19527195

  • 1. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y, Kim E, You M, Pikalov A, Tran QV.
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [Abstract] [Full Text] [Related]

  • 2. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G.
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD006654. PubMed ID: 20238348
    [Abstract] [Full Text] [Related]

  • 4. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
    Zhu B, Kulkarni PM, Stensland MD, Ascher-Svanum H.
    Curr Med Res Opin; 2007 Nov 17; 23(11):2805-14. PubMed ID: 17910804
    [Abstract] [Full Text] [Related]

  • 5. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
    Kim E, You M, Pikalov A, Van-Tran Q, Jing Y.
    BMC Psychiatry; 2011 Jan 07; 11():6. PubMed ID: 21214937
    [Abstract] [Full Text] [Related]

  • 6. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
    Gianfrancesco F, Pesa J, Wang RH.
    J Manag Care Pharm; 2005 Apr 07; 11(3):220-30. PubMed ID: 15804206
    [Abstract] [Full Text] [Related]

  • 7. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
    Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH.
    J Clin Psychiatry; 2006 Feb 07; 67(2):222-32. PubMed ID: 16566617
    [Abstract] [Full Text] [Related]

  • 8. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD006626. PubMed ID: 21249678
    [Abstract] [Full Text] [Related]

  • 9. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
    Stauffer V, Ascher-Svanum H, Liu L, Ball T, Conley R.
    BMC Psychiatry; 2009 Mar 31; 9():13. PubMed ID: 19335905
    [Abstract] [Full Text] [Related]

  • 10. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y, Johnston SS, Fowler R, Bates JA, Forbes RA, Hebden T.
    J Med Econ; 2011 Mar 31; 14(6):777-86. PubMed ID: 21954966
    [Abstract] [Full Text] [Related]

  • 11. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC, Tafesse E, Quon P, Lazarus A.
    Pharmacoeconomics; 2010 Mar 31; 28(9):751-64. PubMed ID: 20623994
    [Abstract] [Full Text] [Related]

  • 12. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
    Kongsakon R, Leelahanaj T, Price N, Birinyi-Strachan L, Davey P.
    J Med Assoc Thai; 2005 Sep 31; 88(9):1267-77. PubMed ID: 16536115
    [Abstract] [Full Text] [Related]

  • 13. Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
    Gianfrancesco F, Rajagopalan K, Goldberg JF, Wang RH.
    Bipolar Disord; 2007 May 31; 9(3):252-61. PubMed ID: 17430300
    [Abstract] [Full Text] [Related]

  • 14. Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
    Olfson M, Gerhard T, Huang C, Lieberman JA, Bobo WV, Crystal S.
    Schizophr Bull; 2012 Jun 31; 38(4):845-53. PubMed ID: 21307041
    [Abstract] [Full Text] [Related]

  • 15. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S.
    Cochrane Database Syst Rev; 2013 Nov 18; (11):CD006625. PubMed ID: 24249315
    [Abstract] [Full Text] [Related]

  • 16. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Perlis RH.
    Am J Manag Care; 2007 Nov 18; 13(7 Suppl):S178-88. PubMed ID: 18041879
    [Abstract] [Full Text] [Related]

  • 17. Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
    Yan T, Greene M, Chang E, Houle CR, Waters HC, Tarbox MH, Broder MS.
    Clin Ther; 2020 Jan 18; 42(1):77-93. PubMed ID: 31928831
    [Abstract] [Full Text] [Related]

  • 18. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
    Lublin H, Haug HJ, Koponen H, Sigmundsson T, Kolb SA.
    World J Biol Psychiatry; 2009 Jan 18; 10(4 Pt 3):710-8. PubMed ID: 18803070
    [Abstract] [Full Text] [Related]

  • 19. Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression.
    Jing Y, Kalsekar I, Curkendall SM, Carls GS, Bagalman E, Forbes RA, Hebden T, Thase ME.
    Clin Ther; 2011 Sep 18; 33(9):1246-57. PubMed ID: 21840058
    [Abstract] [Full Text] [Related]

  • 20. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
    Mladsi DM, Grogg AL, Irish WD, Lopez RB, Degen K, Swann A, Nimsch CT.
    Curr Med Res Opin; 2004 Dec 18; 20(12):1883-93. PubMed ID: 15701206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.